# Vanguard Mid-Cap Value Index Fund Admiral Shares (VMVAX): Mutual Fund Facts & Distributions

> Markdown mirror of https://www.dividenddata.com/funds/vmvax for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Issuer: Vanguard · Asset class: Mid Cap Equity
- Strategy: Passive Index · Inception: 2011-09-27

This affordable index fund offers a pathway to investing in a range of U.S. companies with medium market capitalizations that fall into the 'value' category. These value enterprises are generally identified as businesses whose stock prices are trading below their inherent worth, potentially due to temporary market underappreciation. Such companies typically experience a slower pace of growth when compared to the broader universe of mid-sized firms. A significant risk factor for this investment is that mid-capitalization securities are known to exhibit greater price volatility than stocks of...

## Key Facts

| Metric | Value |
|---|---|
| Price | $108.10 |
| Expense Ratio | 0.07% |
| AUM (All Share Classes) | $36.70B |
| NAV | $108.10 |
| Holdings Count | 186 |
| Distribution Yield (TTM) | 1.85% |
| Annual Distribution (TTM) | $2.00 /share |
| Distribution Frequency | Quarterly |
| 52-Week Range | $87.47 – $109.29 |
| Beta | 0.76 |

## Latest Distribution

- Amount: $0.5300 /share
- Ex-date: 2026-09-28
- Pay date: 2026-09-29

## Frequently Asked Questions

### What does VMVAX invest in?

This affordable index fund offers a pathway to investing in a range of U.S. companies with medium market capitalizations that fall into the 'value' category. These value enterprises are generally identified as businesses whose stock prices are trading below their inherent worth, potentially due to temporary market underappreciation. Such companies typically experience a slower pace of growth when compared to the broader universe of mid-sized firms. A significant risk factor for this investment is that mid-capitalization securities are known to exhibit greater price volatility than stocks of larger, more established companies. It represents a suitable option for investors looking to integrate a passively managed allocation of mid-sized, value-focused companies into an existing, well-diversified investment portfolio.

### What is the expense ratio of VMVAX?

Vanguard Mid-Cap Value Index Fund Admiral Shares (VMVAX) charges an expense ratio of 0.07%. This is the annual fee deducted from fund assets to cover management and operations.

### How big is VMVAX?

Vanguard Mid-Cap Value Index Fund Admiral Shares (VMVAX) is one share class of a fund that manages $36.70B across all of its share classes (VOE reports the same total). Our data does not carry the assets of this share class alone. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation.

### Is VMVAX actively managed or an index fund?

VMVAX is a passive index fund. It tracks a published benchmark by holding the constituents in their published weights. Index funds typically charge low expense ratios (VMVAX's is 0.07%) because there's no security selection cost.

### When was VMVAX launched?

Vanguard Mid-Cap Value Index Fund Admiral Shares (VMVAX) launched in September 2011 and is managed by Vanguard.

### How has VMVAX performed?

VMVAX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.

### Does VMVAX pay a dividend?

Vanguard Mid-Cap Value Index Fund Admiral Shares (VMVAX) currently distributes little or no income. Trailing-twelve-month yield is 1.85%. Investors looking for income should consider income-focused alternatives. See the Peers tab.

### How often does VMVAX pay dividends?

Vanguard Mid-Cap Value Index Fund Admiral Shares pays dividends Quarterly. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is VMVAX's dividend yield?

VMVAX's trailing-twelve-month yield is 1.85%, calculated from the sum of dividends over the past year divided by the current price.

### When is VMVAX's next ex-dividend date?

The most recently announced ex-dividend date for VMVAX was 2026-09-28. The next ex-date typically follows Quarterly; once announced it appears at the top of the dividend history table on this page.

### How much will VMVAX's expense ratio cost me over 30 years?

On a $10,000 investment compounding at 7% gross return, a 0.07% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees.

### How does VMVAX charge its expense ratio?

The expense ratio is deducted in tiny daily slices from VMVAX's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price.

### Why does VMVAX cost more than a fund like VOO?

VMVAX is a passive index fund (current expense ratio 0.07%). Differences from broad-market ETFs like VOO usually come from index licensing fees, asset class (bond funds typically run cheaper than equity), or fund scale (smaller funds spread fixed operating costs across less AUM).

### Are there cheaper alternatives to VMVAX?

The Lower-Fee Alternatives card above lists mutual funds following the same investment strategy as VMVAX (0.07%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/funds/vmvax
- Distribution history: https://www.dividenddata.com/funds/vmvax/dividend
- Holdings & diversification: https://www.dividenddata.com/funds/vmvax/diversification
- Fees & cheaper alternatives: https://www.dividenddata.com/funds/vmvax/expenses
- Peer comparison: https://www.dividenddata.com/funds/vmvax/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.